UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immune signature of pheochromocytoma and paraganglioma in context of neuroendocrine neoplasms associated with prognosis

Endocrine, 2023-01, Vol.79 (1), p.171-179

2023

Volltextzugriff (PDF)

rWTC-MBTA: autologous vaccine prevents metastases via antitumor immune responses

Journal of experimental & clinical cancer research, 2023-07, Vol.42 (1), p.163-163, Article 163

2023

Volltextzugriff (PDF)

PD-L1 expression and association with genetic background in pheochromocytoma and paraganglioma

Frontiers in oncology, 2022-11, Vol.12, p.1045517-1045517

2022

Volltextzugriff (PDF)

Mannan-BAM, TLR ligands, and anti-CD40 immunotherapy in established murine pancreatic adenocarcinoma: understanding therapeutic potentials and limitations

Cancer Immunology, Immunotherapy, 2021-11, Vol.70 (11), p.3303-3312

2021

Volltextzugriff (PDF)

Intratumoral immunotherapy of murine pheochromocytoma shows no age-dependent differences in its efficacy

Frontiers in endocrinology (Lausanne), 2023-05, Vol.14, p.1030412

2023

Volltextzugriff (PDF)

rWTC‐MBTA Vaccine Induces Potent Adaptive Immune Responses Against Glioblastomas via Dynamic Activation of Dendritic Cells

Advanced science, 2024-04, Vol.11 (14), p.e2308280-n/a

2024

Volltextzugriff (PDF)

The Immune Landscape of Pheochromocytoma and Paraganglioma: Current Advances and Perspectives

Endocrine reviews, 2024-07, Vol.45 (4), p.521-552

2024

Volltextzugriff (PDF)

Design of Composite Hybrid Structures “on Request”

Materials today : proceedings, 2016, Vol.3 (4), p.1129-1134

2016

Volltextzugriff (PDF)

Multiscale Modeling of Hybrid Composite Structures

Key engineering materials, 2011, Vol.471-472, p.916-921

2011

Volltextzugriff (PDF)

Effective cancer immunotherapy based on combination of TLR agonists with stimulation of phagocytosis

International immunopharmacology, 2018-06, Vol.59, p.86-96

2018

Volltextzugriff (PDF)

Coley's immunotherapy revived: Innate immunity as a link in priming cancer cells for an attack by adaptive immunity

Seminars in oncology, 2019-08, Vol.46 (4-5), p.385-392

2019

Volltextzugriff (PDF)

Therapeutic Targeting of SDHB -Mutated Pheochromocytoma/Paraganglioma with Pharmacologic Ascorbic Acid

Clinical cancer research, 2020-07, Vol.26 (14), p.3868-3880

2020

Volltextzugriff (PDF)

Role of B cells in intratumoral MBTA immunotherapy of murine pheochromocytoma model

Baillière's best practice & research. Clinical endocrinology & metabolism, 2024-09, p.101941, Article 101941

2024

Volltextzugriff (PDF)

Rapid Cardiovascular Response to Belzutifan in HIF2A -Mediated Paraganglioma

The New England journal of medicine, 2024-10, Vol.391 (16), p.1552-1555

2024

Volltextzugriff (PDF)

Fatigue Properties of the Cell 3D Composite Structure

Applied Mechanics and Materials, 2012-01, Vol.152-154, p.1413-1416

2012

Volltextzugriff (PDF)

The combination of immunotherapy and a glutamine metabolism inhibitor represents an effective therapeutic strategy for advanced and metastatic murine pancreatic adenocarcinoma

International immunopharmacology, 2023-05, Vol.118, p.110150-110150, Article 110150

2023

Volltextzugriff (PDF)

IMMU-44. AN IMMUNOTHERAPEUTIC VACCINE COMPOSED OF IRRADIATED WHOLE TUMOR CELLS PULSED WITH MANNAN-BAM, TLR LIGANDS AND ANTI-CD40 ANTIBODY INDUCES POTENT IMMUNE RESPONSE IN PRECLINICAL GBM ANIMAL MODEL

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi102-vi102

2021

Volltextzugriff (PDF)

PSAT089 Lack of Effect of Metformin in Murine Pheochromocytoma Model

Journal of the Endocrine Society, 2022-11, Vol.6 (Supplement_1), p.A116-A116

2022

Volltextzugriff (PDF)

Germline SUCLG2 Variants in Patients With Pheochromocytoma and Paraganglioma

JNCI : Journal of the National Cancer Institute, 2022-01, Vol.114 (1), p.130-138

2022

Volltextzugriff (PDF)

IMMU-23. TARGETING METASTATIC AND CNS TUMORS VIA MANNAN-BAM, TLR LIGANDS AND ANTI-CD40 ANTIBODY

Neuro-oncology (Charlottesville, Va.), 2019-11, Vol.21 (Supplement_6), p.vi123-vi124

2019

Volltextzugriff (PDF)

Identification of Immune Cell Infiltration in Murine Pheochromocytoma during Combined Mannan-BAM, TLR Ligand, and Anti-CD40 Antibody-Based Immunotherapy

Cancers, 2021-08, Vol.13 (16), p.3942

2021

Volltextzugriff (PDF)

The Significant Reduction or Complete Eradication of Subcutaneous and Metastatic Lesions in a Pheochromocytoma Mouse Model after Immunotherapy Using Mannan-BAM, TLR Ligands, and Anti-CD40

Cancers, 2019-05, Vol.11 (5), p.654

2019

Volltextzugriff (PDF)

Abstract 691: Irradiated whole tumor cells pulsed with mannan-BAM, TLR ligands and anti-CD40 antibody serve as a potent tumor cell vaccine against glioblastoma

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.691-691

2023

Volltextzugriff (PDF)

Abstract 6800: Unique autologous cancer vaccine comprised of irradiated whole tumor cells and MBTA (rWTC-MBTA) triggers antitumor immune response to prevent metastasis

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.6800-6800

2023

Volltextzugriff (PDF)

Systemic Immune Response in Murine Bilateral Pheochromocytoma Model During Immunotherapy Based on a Combination of Mannan-BAM, TLR Ligands and Anti-CD40 Antibodies (MBTA Therapy)

Journal of the Endocrine Society, 2021-05, Vol.5 (Supplement_1), p.A1032-A1033

2021

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(33)
Tagungsberichte
(3)

Sprache

Englisch
(36)
Tschechisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Immune signature of pheochromocytoma and paraganglioma in context of neuroendocrine neoplasms associated with prognosis

rWTC-MBTA: autologous vaccine prevents metastases via antitumor immune responses

PD-L1 expression and association with genetic background in pheochromocytoma and paraganglioma

Mannan-BAM, TLR ligands, and anti-CD40 immunotherapy in established murine pancreatic adenocarcinoma: understanding therapeutic potentials and limitations

Intratumoral immunotherapy of murine pheochromocytoma shows no age-dependent differences in its efficacy

rWTC‐MBTA Vaccine Induces Potent Adaptive Immune Responses Against Glioblastomas via Dynamic Activation of Dendritic Cells

The Immune Landscape of Pheochromocytoma and Paraganglioma: Current Advances and Perspectives

Design of Composite Hybrid Structures “on Request”

Multiscale Modeling of Hybrid Composite Structures

Effective cancer immunotherapy based on combination of TLR agonists with stimulation of phagocytosis

Coley's immunotherapy revived: Innate immunity as a link in priming cancer cells for an attack by adaptive immunity

Therapeutic Targeting of SDHB -Mutated Pheochromocytoma/Paraganglioma with Pharmacologic Ascorbic Acid

Role of B cells in intratumoral MBTA immunotherapy of murine pheochromocytoma model

Rapid Cardiovascular Response to Belzutifan in HIF2A -Mediated Paraganglioma

Fatigue Properties of the Cell 3D Composite Structure

The combination of immunotherapy and a glutamine metabolism inhibitor represents an effective therapeutic strategy for advanced and metastatic murine pancreatic adenocarcinoma

IMMU-44. AN IMMUNOTHERAPEUTIC VACCINE COMPOSED OF IRRADIATED WHOLE TUMOR CELLS PULSED WITH MANNAN-BAM, TLR LIGANDS AND ANTI-CD40 ANTIBODY INDUCES POTENT IMMUNE RESPONSE IN PRECLINICAL GBM ANIMAL MODEL

PSAT089 Lack of Effect of Metformin in Murine Pheochromocytoma Model

Germline SUCLG2 Variants in Patients With Pheochromocytoma and Paraganglioma

IMMU-23. TARGETING METASTATIC AND CNS TUMORS VIA MANNAN-BAM, TLR LIGANDS AND ANTI-CD40 ANTIBODY

Identification of Immune Cell Infiltration in Murine Pheochromocytoma during Combined Mannan-BAM, TLR Ligand, and Anti-CD40 Antibody-Based Immunotherapy

The Significant Reduction or Complete Eradication of Subcutaneous and Metastatic Lesions in a Pheochromocytoma Mouse Model after Immunotherapy Using Mannan-BAM, TLR Ligands, and Anti-CD40

Abstract 691: Irradiated whole tumor cells pulsed with mannan-BAM, TLR ligands and anti-CD40 antibody serve as a potent tumor cell vaccine against glioblastoma

Abstract 6800: Unique autologous cancer vaccine comprised of irradiated whole tumor cells and MBTA (rWTC-MBTA) triggers antitumor immune response to prevent metastasis

Systemic Immune Response in Murine Bilateral Pheochromocytoma Model During Immunotherapy Based on a Combination of Mannan-BAM, TLR Ligands and Anti-CD40 Antibodies (MBTA Therapy)

Suchergebnisse filtern